1[2]Hanna Szwed, Robert Pachocki, Malgorzata Domzal-Bochenska, et al. Efficacy and tolerance of trimetazidine combination with a conventional antianginal drug in pations with stable effort angina. Diaagpmpsos and Treatment in Cardiology, 1997, 4: 237.
2[3]Chunzeng LU, Pawel Dabrowski, Gabriele Fragasso, et al. Effects of trimetazidine on ischemic left ventricular dysflmction in patients with coronary artery disease. American Journal of Cardiology, 1998, 82.
3[4]Brotier L, Barat JL, Combe C, et al. Therapeutic value of a cardioprotective agent in patients with severe ischaemic cardiomyopathy. Eur Hur Heart J, 1990, 11: 207.
4[5]Shlyakhto EV, Vakhrameyeva IV, Nifontoff EM, et al. Chriomic effects of myocarcdial cytoprotector trimetazidine for CAD: clincal, biochemical and echocardiographical follow-up[abstract]. Eur Heart J, 1998, 19 Abstract (suppl): 191.
3Lagadic-Gossann D, Le Prigent K, Feuvay D. Effect of trimetazidine on pH regulation in the rat isolated ventricular myocyte[J]. Br J Pharmacol, 1996,117:831-838
4Allibardi S, Chierchia SL, Margonato V, et al. Effects of trimetazidine on metabolic andfunctional recovery of postischenic rat hearts[J]. Cardiovasc Drugs Ther 1998,12:543-549
5Morin D, Elimadi A, Sapena R, et al. Evidence for the existence of [3H]trimetazidine binding sites involved in the regulation of the mitochondrial permeability transition pore[J]. Br J Pharmacol, 1998,123:1385-1394
6Lu C,Dabrowski P,Fragasso G,et al.Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease[].The American Journal of Cardiology.1998
7Mohand-Said S,Jacquet A,Lucien A,et al.Protective effect of trimetazi-dine in a model of ischemia-reerfusion in the rat retina[]..2002
